Grant funding success for BMT and Haematology research team

The Bristol Haematology and Oncology Centre Clinical Trials Unit has been awarded funds to support clinical trials in haematology and stem cell transplantation over the next three years. The funding, equivalent to one and a half team members, will support Bone Marrow Transplant and Haematology clinical trials for emerging lymphoma, myeloma, leukaemia and other blood cancer treatments.

The funds are awarded by the IMPACT (Partnership for Accelerated Clinical Trials) and TAP (Trials Acceleration Programme) schemes. BHOC was one of 23 centres applying for these competitive funds and received the highest amount of funding available for our centre. Following the recent grant success of the NIHR Bristol Clinical Research Facility, these funds are a further boost to the clinical research team at the BHOC CTU. This funding also brings access to a network of specialist organisations that are coordinating research in these complex fields.